Academic Journal
Q1The Lancet
About The Lancet
The Lancet is a scholarly journal published by Elsevier B.V.. SCImago 2025 places it in Q1 with an SJR of 14.821 and an H-index of 982.
Its listed coverage is 1823-2026 and its research categories include Medicine (miscellaneous) (Q1). The 2025 dataset reports 1292 documents and 59974 citations across the latest three-year reporting window.
The Lancet, founded in 1823 by Thomas Wakley, is one of the world’s most influential and esteemed medical journals. Renowned for its cutting-edge research and authoritative reviews, The Lancet has earned a reputation as a leading voice in global health. It continues to provide a platform for scientific inquiry and thought leadership, influencing medical practices, public health policies, and the global healthcare landscape.
A Legacy of Impactful Research
The Lancet is known for publishing groundbreaking research across a wide range of medical disciplines, including public health, infectious diseases, oncology, neurology, and more. Each issue of the journal features high-quality, peer-reviewed studies that address the most pressing health challenges of our time. The journal has been instrumental in advancing scientific knowledge, offering clinicians, researchers, and policymakers a wealth of evidence-based insights.
One of the journal’s core strengths lies in its commitment to publishing studies that not only expand scientific understanding but also push for real-world change. For example, The Lancet has long been at the forefront of addressing issues such as global health disparities, non-communicable diseases, and the social determinants of health. With an unwavering focus on improving health outcomes worldwide, The Lancet continues to shape policy debates and inform the development of innovative healthcare solutions.
Global Reach and Influence
The Lancet’s influence extends far beyond academia. It plays a critical role in shaping global health discussions by publishing research that informs policy, drives medical innovation, and guides healthcare delivery worldwide. With a readership that includes policymakers, medical professionals, and global health leaders, The Lancet’s impact resonates across various sectors, from clinical practice to public health initiatives.
The journal’s international reach is a key component of its success. Its content is accessible to a diverse, global audience, ensuring that critical health information is shared across borders. Whether tackling issues such as climate change, antimicrobial resistance, or vaccine equity, The Lancet’s global perspective ensures that its research has broad relevance and impact.
Leading the Charge on Global Health Challenges
The Lancet has consistently been at the forefront of addressing some of the world’s most pressing health challenges. During the COVID-19 pandemic, The Lancet played a pivotal role in disseminating vital research, contributing to the scientific community’s understanding of the virus, its transmission, and the strategies needed to combat it. The journal’s timely reporting and editorial commentary provided guidance during the rapidly evolving global crisis.
The Lancet also continues to lead discussions on other urgent issues such as climate change, mental health, and universal healthcare access. By publishing articles that explore the intersection of health with social, environmental, and economic factors, The Lancet fosters a holistic approach to global health.
Commitment to Diversity and Inclusion
The Lancet is not only committed to advancing medical research but also to ensuring that diverse voices are represented in the global health conversation. It recognizes the importance of inclusivity in healthcare, advocating for equitable access to care and highlighting disparities in health outcomes. Through its editorial content, The Lancet strives to amplify the voices of marginalized populations and ensure that the health needs of all communities are addressed.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The Lancet is one of the world’s most influential and respected medical journals. Founded in 1823 by Thomas Wakley, it has continuously provided a platform for the latest and most significant research in medicine, public health, and clinical science. As a peer-reviewed medical journal, The Lancet's scope encompasses a vast array of topics related to healthcare, disease prevention, treatment methodologies, and the overall well-being of populations worldwide.
Broad Range of Medical Disciplines
The Lancet's scope is vast, covering a wide range of medical disciplines. It publishes groundbreaking research across multiple areas, including clinical trials, epidemiology, global health, and public policy. Some of the key topics regularly featured in The Lancet include cardiovascular diseases, infectious diseases, oncology, neurology, immunology, and mental health.
The journal has an international focus, making it a valuable resource for healthcare professionals and researchers from various specialties. Whether it’s cutting-edge studies on rare diseases or the latest advancements in cancer treatment, The Lancet consistently brings the most relevant and impactful research to the forefront of medical science.
Global Health and Public Policy
One of the most significant contributions of The Lancet is its focus on global health issues. The journal regularly publishes studies related to the global burden of disease, health disparities, and the impact of health policy on populations. The Lancet's coverage of health issues in low- and middle-income countries, such as infectious diseases, maternal and child health, and malnutrition, has shaped global health initiatives and informed policy decisions worldwide.
In addition to medical research, The Lancet also tackles public policy issues, providing an important platform for experts in global health and economics. This interdisciplinary approach ensures that the journal not only covers the clinical and scientific aspects of healthcare but also addresses broader issues such as healthcare access, economics, and ethics.
Special Issues and Series
The Lancet is known for its special issues and series that focus on particular topics in-depth. These series often bring together expert opinions, research findings, and commentary on urgent medical and health challenges. For instance, The Lancet has published special series on climate change and its impact on health, the opioid crisis, and the COVID-19 pandemic, which have attracted attention from policymakers, researchers, and the general public alike.
These special issues provide a comprehensive understanding of complex medical and health challenges and offer insights into potential solutions. By gathering research and perspectives from around the globe, The Lancet helps drive important conversations that shape healthcare practices and policies.
Editorials, Reviews, and Commentaries
In addition to original research articles, The Lancet features editorial pieces, reviews, and commentaries that offer expert insights on various medical issues. These articles provide context to the research published in the journal and offer an analysis of current trends, treatment options, and policy changes in the medical field. This makes The Lancet not only a publication for research but also a platform for informed discussions on the future of healthcare and medicine.
Commitment to High Standards
The Lancet maintains rigorous peer-review processes to ensure the integrity and quality of the research it publishes. This commitment to scientific rigor is a cornerstone of the journal’s reputation and its importance in the medical community. The Lancet’s editorial board consists of leading experts from various fields of medicine, which helps ensure that the research published in the journal is relevant, reliable, and of the highest quality.
Recent Research Articles
Latest publications matched automatically by ISSN.
How will the Meta settlement affect child health?
Talha Burki
2026-09 · DOI: 10.1016/s0140-6736(26)01807-6Health should be key to transitioning away from fossil fuels
Robbie M Parks, Julianna Gwiszcz, Jessica Newberry Le Vay, Ebba Malmqvist et al.
2026-09 · DOI: 10.1016/s0140-6736(26)01538-2Adverse pregnancy outcomes and long-term cardiovascular disease risk
Maria A Pabón, Graeme Smith, Garima Sharma, Janet Catov et al.
2026-09 · DOI: 10.1016/s0140-6736(26)01235-3US–African data sharing agreements come under scrutiny
Paul Webster
2026-09 · DOI: 10.1016/s0140-6736(26)01808-8Charting a path to health for all at net-zero emissions
Judith Rodin, Jennifer R Bratburd, Noah Duff, Jonathan A Patz et al.
2026-09 · DOI: 10.1016/s0140-6736(25)00813-xGold standard vaccine policy as a global health signal
Mauer Alexandre da Ascensão Gonçalves, Aguinaldo Filipe de Morais, Capela António Pascoal, Carlos Victor Montefusco-Pereira et al.
2026-09 · DOI: 10.1016/s0140-6736(26)01698-3Robotic-arm-assisted versus conventional total knee replacement (RACER-Knee): a pragmatic, multicentre, participant-masked and assessor-masked, superiority, randomised controlled trial
Helen Parsons, Andrew Metcalfe, James Griffin, Chetan Khatri et al.
2026-09 · DOI: 10.1016/s0140-6736(26)00986-4Liposuction versus conservative therapy for patients with lipoedema in Germany: a multicentre, randomised controlled clinical trial
Maurizio Podda, Jeremias Schmidt, Manuel E Cornely, Marten I Steinmetz et al.
2026-09 · DOI: 10.1016/s0140-6736(26)00910-4The girl who danced with fire
Marco De Ambrogi
2026-09 · DOI: 10.1016/s0140-6736(26)01774-5Cardiovascular disease in pregnancy: physiology, global burden, risk stratification, and opportunities in care
Tiffany L Brazile, Nathalie Conrad, Lina Bergman, Justin Paul Gnanaraj et al.
2026-09 · DOI: 10.1016/s0140-6736(26)01234-1Porcine kidney xenotransplantation as a bridge to allotransplantation: a first-in-human study
Leonardo V Riella, Thiago J Borges, Ivy A Rosales, Claire T Avillach et al.
2026-09 · DOI: 10.1016/s0140-6736(26)01295-xDisability expertise: a paediatrician with cerebral palsy in Japan
Shin-ichiro Kumagaya, Michele Ilana Friedner, Junko Kitanaka, Kiyoto Kasai et al.
2026-09 · DOI: 10.1016/s0140-6736(26)01775-7Redefining the end of Uganda's Ebola virus crisis
Serge Tonen-Wolyec, Laurent Bélec
2026-09 · DOI: 10.1016/s0140-6736(26)01614-4Safety and lipoprotein(a)-lowering effects of Kylo-11, a non-canonical, long-duration small interfering RNA targeting lipoprotein(a): a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial
Ashish Sarraju, Xiaolin Du, Luping Zhou, Luke J Laffin et al.
2026-09 · DOI: 10.1016/s0140-6736(26)01484-4Wealth redistribution policies to mitigate the impact of development assistance defunding: a retrospective evaluation and forecasting analysis up to 2030
Gonzalo Barreix Sibils, Rodrigo Volmir Rezende Anderle, Andrea Ferreira da Silva, Lucas de Oliveira Ferreira de Sales et al.
2026-09 · DOI: 10.1016/s0140-6736(26)00975-xIntersectionality in climate and health equity research
Aaron Koay, Gurpreet Kaur, Muskaan Khepla, Renzo R Guinto et al.
2026-09 · DOI: 10.1016/s0140-6736(26)01417-0Reimagining maternal cardiovascular health
The Lancet
2026-09 · DOI: 10.1016/s0140-6736(26)01759-9BAFF-R CAR T-cell therapy for relapsed or refractory B-cell lymphomas
Lihua E Budde, Marissa M Del Real, Joo Y Song, Lu Chen et al.
2026-09 · DOI: 10.1016/s0140-6736(26)01329-2The imperative for the global community to save the Paris Climate Agreement
Shilu Tong, Hilary Bambrick, Jason Prior, Eric Lavigne et al.
2026-09 · DOI: 10.1016/s0140-6736(25)01946-4Late-onset seizures as a sentinel of Alzheimer's disease progression in Down syndrome
Zinayida Schlachetzki, Michael S Rafii
2026-09 · DOI: 10.1016/s0140-6736(26)00959-1Reviews
Community Reviews
Version History
April 13, 2025 at 5:35 pm
April 13, 2025